CA Stock MarketDetailed Quotes

PRM Big Pharma Split Corp

Watchlist
  • 13.400
  • -0.100-0.74%
15min DelayMarket Closed Dec 27 16:00 ET
15.15MMarket Cap13.54P/E (TTM)

Big Pharma Split Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
(FY)Dec 31, 2017
Operating cash flow (Indirect Method)
Cash flow from continuing operating activities
1.27M
Net income from continuing operations
-127.01%-645.35K
-43.24%2.39M
2,036.51%4.21M
-108.43%-217.39K
22.57%2.58M
761.50%2.1M
---318.2K
Operating gains losses
----
----
----
----
----
--931.04K
----
Unrealized gains and losses of investment securities
----
----
----
----
----
---4.09M
----
Other non cashItems
48.98%-2.12K
98.21%-4.16K
---231.53K
----
----
--2.38M
----
Change in working capital
-94.49%9.66K
213.67%175.39K
-386.97%-154.29K
-951.93%-31.68K
94.42%-3.01K
-199.72%-53.96K
--54.11K
-Change in other current liabilities
-94.49%9.66K
213.67%175.39K
-386.97%-154.29K
-951.93%-31.68K
---3.01K
----
--54.11K
Cash from discontinued operating activities
Operating cash flow
950.88%11.86M
112.54%1.13M
-306.98%-9M
-49.90%4.35M
583.04%8.68M
104.11%1.27M
---30.95M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-2.71M
Net commonstock issuance
-1,431.26%-5.32M
-94.72%399.78K
549.06%7.57M
53.89%-1.69M
-1,280.08%-3.66M
-101.30%-265.09K
--20.4M
Net preferred stock issuance
-1,147.51%-5.04M
-91.63%481.16K
565.60%5.75M
56.34%-1.23M
-1,380.17%-2.83M
-101.40%-191K
--13.6M
Cash dividends paid
19.39%-2.11M
7.76%-2.62M
-63.83%-2.84M
16.93%-1.73M
7.53%-2.08M
---2.25M
--0
Net other financing activities
--0
--0
--0
--0
--0
----
--0
Cash from discontinued financing activities
Financing cash flow
-617.83%-12.47M
-117.04%-1.74M
319.13%10.19M
45.71%-4.65M
-216.27%-8.57M
-108.28%-2.71M
--32.74M
Net cash flow
Beginning cash position
-42.71%819.21K
518.99%1.43M
-56.91%230.99K
28.53%536.06K
-77.40%417.07K
--1.85M
--0
Current changes in cash
-0.58%-612.38K
-151.02%-608.87K
493.10%1.19M
-376.37%-303.61K
107.64%109.86K
-180.79%-1.44M
--1.78M
Effect of exchange rate changes
-51.61%-2.64K
-132.49%-1.74K
467.60%5.36K
-115.96%-1.46K
-12.12%9.13K
-83.89%10.39K
--64.48K
End cash position
-75.07%204.19K
-42.71%819.21K
518.99%1.43M
-56.91%230.99K
28.53%536.06K
-77.40%417.07K
--1.85M
Free cash from
950.88%11.86M
112.54%1.13M
-306.98%-9M
-49.90%4.35M
583.04%8.68M
104.11%1.27M
---30.95M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018(FY)Dec 31, 2017
Operating cash flow (Indirect Method)
Cash flow from continuing operating activities 1.27M
Net income from continuing operations -127.01%-645.35K-43.24%2.39M2,036.51%4.21M-108.43%-217.39K22.57%2.58M761.50%2.1M---318.2K
Operating gains losses ----------------------931.04K----
Unrealized gains and losses of investment securities -----------------------4.09M----
Other non cashItems 48.98%-2.12K98.21%-4.16K---231.53K----------2.38M----
Change in working capital -94.49%9.66K213.67%175.39K-386.97%-154.29K-951.93%-31.68K94.42%-3.01K-199.72%-53.96K--54.11K
-Change in other current liabilities -94.49%9.66K213.67%175.39K-386.97%-154.29K-951.93%-31.68K---3.01K------54.11K
Cash from discontinued operating activities
Operating cash flow 950.88%11.86M112.54%1.13M-306.98%-9M-49.90%4.35M583.04%8.68M104.11%1.27M---30.95M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -2.71M
Net commonstock issuance -1,431.26%-5.32M-94.72%399.78K549.06%7.57M53.89%-1.69M-1,280.08%-3.66M-101.30%-265.09K--20.4M
Net preferred stock issuance -1,147.51%-5.04M-91.63%481.16K565.60%5.75M56.34%-1.23M-1,380.17%-2.83M-101.40%-191K--13.6M
Cash dividends paid 19.39%-2.11M7.76%-2.62M-63.83%-2.84M16.93%-1.73M7.53%-2.08M---2.25M--0
Net other financing activities --0--0--0--0--0------0
Cash from discontinued financing activities
Financing cash flow -617.83%-12.47M-117.04%-1.74M319.13%10.19M45.71%-4.65M-216.27%-8.57M-108.28%-2.71M--32.74M
Net cash flow
Beginning cash position -42.71%819.21K518.99%1.43M-56.91%230.99K28.53%536.06K-77.40%417.07K--1.85M--0
Current changes in cash -0.58%-612.38K-151.02%-608.87K493.10%1.19M-376.37%-303.61K107.64%109.86K-180.79%-1.44M--1.78M
Effect of exchange rate changes -51.61%-2.64K-132.49%-1.74K467.60%5.36K-115.96%-1.46K-12.12%9.13K-83.89%10.39K--64.48K
End cash position -75.07%204.19K-42.71%819.21K518.99%1.43M-56.91%230.99K28.53%536.06K-77.40%417.07K--1.85M
Free cash from 950.88%11.86M112.54%1.13M-306.98%-9M-49.90%4.35M583.04%8.68M104.11%1.27M---30.95M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.